Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
10.1038/s41467-023-40829-2
Saved in:
Main Authors: | Kim, YN, Park, B, Kim, JW, Kim, BG, Kim, SW, Kim, HS, Choi, CH, Lim, MC, YL Ngoi, N, SP Tan, D, Lee, JY |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Springer Science and Business Media LLC
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/245266 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
by: Lee, Yong Jae, et al.
Published: (2021) -
Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer
by: Huang, R.Y.-J., et al.
Published: (2014) -
Epithelial ovarian cancer
by: Ng, J.S., et al.
Published: (2016) -
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
by: Huang, R.Y.-J., et al.
Published: (2014) -
SERS-based detection of haptoglobin in ovarian cyst fluid as a point-of-care diagnostic assay for epithelial ovarian cancer
by: Perumal, J., et al.
Published: (2022)